Microcap Ledger

Tickers · $NAII

Natural Alternatives International Inc $NAII

By Microcap Ledger desk · CIK 0000787253

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Global Market
Sector
Medicinal Chemicals & Botanical Products
Headquarters
Carlsbad, CA
Fiscal year end
June 30
Shares outstanding
22,113,000 [10-K 2026-09-28]
as of 2026-09-28

Sources: [10-K 2026-09-28]

What the company doesAI summary of filing

Natural Alternatives International manufactures nutritional supplements on a private-label contract basis for companies that market vitamins, minerals, herbs, and other nutritional products to consumers in the U.S. and internationally. The company also commercializes its patent estate related to beta-alanine raw material through direct sales and licensing under the CarnoSyn®, SR CarnoSyn®, CarnoSyn® 4X, and TriBsyn® trademarks. In fiscal 2026, the company generated $142.5 million in revenue, with 94 percent from private-label contract manufacturing and 6 percent from patent and trademark licensing. The company operates manufacturing facilities in California and Switzerland and is a revenue-generating business. [10-K 2026-09-28]

Segments: Private-label contract manufacturing, Patent and trademark licensing (beta-alanine)

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
105 months to Sep 2031$32.70M−$2.38M ——[10-Q 2023-05-15]
FY ended Jun 2026$142.51M−$20.70M −$8.92M$7.39M[10-K 2026-09-28]
FY ended Jun 2025$129.86M−$13.57M $5.93M$12.32M[10-K 2026-09-28]

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-11-136,198,778[10-Q 2024-11-13]
2025-02-146,198,778[10-Q 2025-02-14]
2025-05-146,178,898[10-Q 2025-05-14]
2025-09-236,176,778[10-K 2025-09-23]
2025-11-126,176,778[10-Q 2025-11-12]
2026-02-136,176,778[10-Q 2026-02-13]
2026-05-186,275,229[10-Q 2026-05-19]
2026-09-2822,113,000[10-K 2026-09-28]

Listing status

Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-03-06Wolf Kennethother5,151$2.73[4 2026-03-10]
2026-03-06Wolf Kennethgrant15,000—[4 2026-03-10]
2026-03-06Fortin Michael Eother4,308$2.73[4 2026-03-10]
2026-03-06Fortin Michael Egrant12,000—[4 2026-03-10]
2026-03-06Ledoux Mark Aother3,484$2.73[4 2026-03-10]
2026-03-06Ledoux Mark Agrant20,000—[4 2026-03-10]
2026-03-06Dunn Alan Ggrant8,000—[4 2026-03-10]
2026-03-06Matherly Laura Kaygrant8,000—[4 2026-03-10]
2026-03-06Ramanathan Gurugrant8,000—[4 2026-03-10]
2026-03-06Ledoux Mark Abuy532$2.80[4 2026-03-06]
2026-03-05Ledoux Mark Abuy218$2.75[4 2026-03-06]
2026-03-04Ledoux Mark Abuy500$2.77[4 2026-03-06]

Catalysts and calendar

Recent filings and releases
DateTypeTitle
2026-09-2810-KAnnual report
2026-05-1910-QQuarterly report
2026-05-18NT 10-QNotice of late quarterly report
2026-05-018-KDirector or officer change
2026-03-208-KDirector or officer change
2026-02-1310-QQuarterly report
2026-01-2113G/ABeneficial ownership report (5%+ holder)
2025-12-178-KMaterial agreement entered
2025-12-128-KShareholder vote results
2025-11-1210-QQuarterly report
2025-10-23DEF 14AProxy statement

Facts as of . Small caps move fast; check the latest filings.